Literature DB >> 27297635

Diagnosis of imported Ugandan typhoid fever based on local outbreak information: A case report.

Shinichiro Ota1, Yohei Maki1, Kazuma Mori1, Takaaki Hamamoto2, Atsushi Kurokawa1, Masashi Ishihara1, Takayuki Yamamoto1, Kazuo Imai1, Kazuhisa Misawa1, Atsushi Yuki2, Yuji Fujikura1, Takuya Maeda3, Akihiko Kawana1.   

Abstract

Re-emerging multidrug-resistant typhoid fever is becoming a worldwide threat, especially in East Africa. At the beginning of 2015, an outbreak of typhoid fever started in the capital city of Uganda, and 1940 suspected cases were reported by 5 March 2015. In this report, we describe a case of typhoid fever caused by a MDR strain with HIV infection and hemoglobin S-syndrome thalassemia in an Ugandan from Kampala City. It is essential to consider MDR strains of Salmonella enterica serovar Typhi infections, including fluoroquinolone-resistant strains, in patients from Africa and Southeast Asia.
Copyright © 2016 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Fluoroquinolone; Multidrug resistance; Salmonella enterica; Typhoid fever; Uganda

Mesh:

Year:  2016        PMID: 27297635     DOI: 10.1016/j.jiac.2016.05.004

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  2 in total

1.  Factors associated with Salmonella infection in patients with gastrointestinal complaints seeking health care at Regional Hospital in Southern Highland of Tanzania.

Authors:  Fadhili A Ngogo; Agricola Joachim; Ahmed M Abade; Susan F Rumisha; Mucho M Mizinduko; Mtebe V Majigo
Journal:  BMC Infect Dis       Date:  2020-02-12       Impact factor: 3.090

2.  Prevalence, Serotype Distribution and Antimicrobial Resistance of Non-Typhoidal Salmonella in Hospitalized Patients in Conghua District of Guangzhou, China.

Authors:  Baiyan Gong; Hong Li; Yulian Feng; Shihan Zeng; Zhenxu Zhuo; Jiajun Luo; Xiankai Chen; Xiaoyan Li
Journal:  Front Cell Infect Microbiol       Date:  2022-02-02       Impact factor: 5.293

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.